Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination of three drugs used for regional anesthesia and pain management. Bupivacaine is an amide local anesthetic that blocks nerve impulse generation and conduction by inhibiting voltage-gated sodium channels. Epinephrine is added to reduce systemic absorption of bupivacaine, thereby prolonging its local effect and reducing the risk of toxicity. Clonidine, an alpha-2 adrenergic agonist, enhances and prolongs the analgesic effects of bupivacaine. This combination is commonly used in epidural anesthesia, nerve blocks, and periarticular injections for postoperative pain management.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bupivacaine + epinephrine + clonidine.